The regulatory landscape for the life sciences continues to evolve rapidly as the rate of technological advancement within the sector - the development of new drug modalities and the application of digital technology, for example - continues apace. The new Labour government in the UK has also indicated that it will reform regulation to make pathways easier and quicker to navigate.
What are the current regulatory trends for both medicines and medical devices and how do we see regulation developing over the short and mid-term? What do businesses in the sector need to watch out for?
Our Head of Sector James Fry will be joined by Isabel Teare, along with regulatory consultants Alisdair Falconer at DLRC, and Timothy Bubb at iMed, to give their collective expert views on these issues.
If you need any adjustments to take part in this webinar, let us know using our requirements form.
By signing up Mills & Reeve will use the information you provide in accordance with our privacy policy. We may from time to time send you general updates by email or post that we think you will find of interest. This includes notification of upcoming events and updates or alerts containing relevant legal news. You can update your preferences at any time and will be able to easily unsubscribe from anything that you do not wish to receive.
We may record and share the webinar on our YouTube channel, with delegates. By joining this webinar session, you acknowledge that this session will be recorded and understand that we will take reasonable steps to protect the privacy of participants such as capturing video only of the Mills & Reeve hosts, not capturing chat text and responding to questions anonymously. Further information is available in our privacy policy for online meetings and voice calls.